Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting.

BACKGROUND Superparamagnetic nanoparticles are currently used as contrast agents for magnetic resonance imaging. These particles can also be used as drug carriers for local chemotherapy, called magnetic drug targeting. Using an external magnetic field, colloidal nanoparticles can be directed to a specific body compartment (i.e. tumor). MATERIALS AND METHODS After magnetic drug targeting in an experimental rabbit model with a VX2 squamous cell carcinoma, tumor tissue was extracted and embedded in paraffin for histology and X-ray imaging. RESULTS The distribution of magnetic nanoparticles was detected holistically with X-ray imaging and in detail using Prussian blue staining of histological cross sections. CONCLUSION The biodistribution of magnetic nanoparticles can be visualized with X-ray imaging and histologically confirmed.

[1]  W. Erhardt,et al.  Magnetisches Drug Targeting—ein neuer Ansatz in der lokoregionären Tumortherapie mit Chemotherapeutika , 2005, HNO.

[2]  C. Alexiou,et al.  In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles , 2005 .

[3]  V. Torchilin,et al.  Drug targeting. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  H Heynemann,et al.  Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation , 2001, International journal of cancer.

[5]  C. Alexiou,et al.  Distribution of Mitoxantrone after Magnetic Drug Targeting: Fluorescence Microscopic Investigations on VX2 Squamous Cell Carcinoma Cells , 2006 .

[6]  Miqin Zhang,et al.  Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[7]  M. Taupitz,et al.  Detection of lymph node metastases in the VX2 rabbit tumor model , 2000 .

[8]  J. Alksne,et al.  Magnetically controlled metallic thrombosis of intracranial aneurysms , 1966 .

[9]  J M Collins,et al.  Pharmacologic rationale for regional drug delivery. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  C T Hung,et al.  Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats. , 1990, Life sciences.

[11]  Christoph Alexiou,et al.  Magnetic Drug Targeting—Biodistribution of the Magnetic Carrier and the Chemotherapeutic agent Mitoxantrone after Locoregional Cancer Treatment , 2003 .

[12]  C. Alexiou,et al.  Locoregional cancer treatment with magnetic drug targeting. , 2000, Cancer research.

[13]  Christoph Alexiou,et al.  Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. , 2003, Journal of drug targeting.